Michael Petusky
Stock Analyst at Barrington Research
(2.49)
# 2,361
Out of 4,761 analysts
176
Total ratings
49.35%
Success rate
-0.79%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintains: Outperform | $108 → $95 | $63.02 | +50.75% | 28 | Feb 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $82 → $90 | $77.24 | +16.52% | 12 | Jan 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $114 → $115 | $103.16 | +11.48% | 17 | Jan 29, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $32 → $33 | $32.00 | +3.13% | 12 | Jan 14, 2025 | |
| MODV ModivCare | Maintains: Outperform | $25 → $10 | $5.05 | +98.02% | 13 | Jan 14, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $108 | $84.21 | +28.25% | 21 | Nov 21, 2024 | |
| VRME VerifyMe | Maintains: Outperform | $1.5 | $0.94 | +59.57% | 8 | Nov 13, 2024 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 | $1.68 | +33.93% | 11 | Nov 8, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $36 → $24 | $18.75 | +28.00% | 19 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $92 → $93 | $99.54 | -6.57% | 8 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $37 → $25 | $17.39 | +43.76% | 15 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.61 | - | 6 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $34.85 | - | 6 | May 30, 2024 |
Haemonetics
Feb 7, 2025
Maintains: Outperform
Price Target: $108 → $95
Current: $63.02
Upside: +50.75%
Henry Schein
Jan 30, 2025
Maintains: Outperform
Price Target: $82 → $90
Current: $77.24
Upside: +16.52%
Merit Medical Systems
Jan 29, 2025
Maintains: Outperform
Price Target: $114 → $115
Current: $103.16
Upside: +11.48%
Option Care Health
Jan 14, 2025
Maintains: Outperform
Price Target: $32 → $33
Current: $32.00
Upside: +3.13%
ModivCare
Jan 14, 2025
Maintains: Outperform
Price Target: $25 → $10
Current: $5.05
Upside: +98.02%
U.S. Physical Therapy
Nov 21, 2024
Maintains: Outperform
Price Target: $108
Current: $84.21
Upside: +28.25%
VerifyMe
Nov 13, 2024
Maintains: Outperform
Price Target: $1.5
Current: $0.94
Upside: +59.57%
OPKO Health
Nov 8, 2024
Maintains: Outperform
Price Target: $2.25
Current: $1.68
Upside: +33.93%
DENTSPLY SIRONA
Nov 8, 2024
Maintains: Outperform
Price Target: $36 → $24
Current: $18.75
Upside: +28.00%
LeMaitre Vascular
Nov 1, 2024
Maintains: Outperform
Price Target: $92 → $93
Current: $99.54
Upside: -6.57%
Nov 1, 2024
Maintains: Outperform
Price Target: $37 → $25
Current: $17.39
Upside: +43.76%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $5.61
Upside: -
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $34.85
Upside: -